Product Images Tadalafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Tadalafil NDC 70954-628 by Ani Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
fig-1 - fig 1
This text appears to be showing the difference in blood pressure values (Systolic and Diastolic) between participants taking Tadalafil and Placebo. The table seems to include data for both standing and supine positions over a period of time in hours.*
fig-2 - fig 2
This information appears to be a comparison of blood pressure measurements after taking Tadalafil 20 mg and doxazosin 8 mg compared to a placebo and doxazosin 8 mg over a period of time post-dose. The chart shows systolic blood pressure readings at different time points (in hours) after the dose was administered. The data is presented for evaluation of the effects of the medications on blood pressure.*
fig-3 - fig 3
This information shows the systolic blood pressure measurements at different time points after the administration of different combinations of tadalafil and doxazosin. The combinations include 20 mg tadalafil with 8 mg doxazosin, placebo with 8 mg doxazosin, and different timing of tadalafil and placebo administration. The data indicates a comparison of the effects of these treatments on systolic blood pressure.*
fig-4 - fig 4
fig-5 - fig 5
fig-6 - fig 6
fig-7 - fig 7
label-1 - label 1
This is a description of a medication containing 5 mg of tadalafil in chewable tablet form. It is recommended to store the tablets at a temperature between 20°C to 25°C. The tablets should be chewed completely before swallowing and kept out of reach of children. The medication should be dispensed in a tight container. This product is distributed by ANI Pharmaceuticals, Inc. and the information was issued in June 2024. It is important not to swallow the tablets whole.*
label-2 - label 2
This is information from the label of Chewtadzy™ (tadalafil) 10 mg chewable tablets. The tablets should be chewed completely before swallowing and not swallowed whole. The recommended dosage can be found in the prescribing information. It should be stored at 20°C to 25°C, with excursions permitted to 15°C to 30°C. This medication must be kept out of reach of children and dispensed in a tight container. Distributed by ANI Pharmaceuticals, Inc.*
label-3 - label 3
This is a pharmaceutical product label for "CHEWTADZYTadalafil Chewable Tablets" containing 20 mg of tadalafil per tablet. The recommended dosage should be consulted from the Prescribing Information. The tablets must be chewed completely before swallowing. The medication should be stored at 20°C to 25°C, excursions permitted to 15°C to 30°C. It is important to keep this medication out of the reach of children. The product is distributed by ANI Pharmaceuticals, Inc. with an expiration date and serial number provided.*
structure - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
